These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 8764597

  • 1. Kynurenine disposition in blood and brain of mice: effects of selective inhibitors of kynurenine hydroxylase and of kynureninase.
    Chiarugi A, Carpenedo R, Moroni F.
    J Neurochem; 1996 Aug; 67(2):692-8. PubMed ID: 8764597
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of mitochondria and o-methoxybenzoylalanine on 3-hydroxyanthranilic acid dioxygenase activity and quinolinic acid synthesis.
    Chiarugi A, Moroni F.
    J Neurochem; 1999 Mar; 72(3):1125-32. PubMed ID: 10037484
    [Abstract] [Full Text] [Related]

  • 7. Kynurenine hydroxylase and kynureninase inhibitors as tools to study the role of kynurenine metabolites in the central nervous system.
    Moroni F, Carpenedo R, Chiarugi A.
    Adv Exp Med Biol; 1996 Mar; 398():203-10. PubMed ID: 8906267
    [No Abstract] [Full Text] [Related]

  • 8. Enantiospecific synthesis and in vitro activity of selective inhibitors of rat brain kynureninase and kynurenine-3-hydroxylase.
    Giordani A, Corti L, Cini M, Bormetti R, Marconi M, Veneroni O, Speciale C, Varasi M.
    Adv Exp Med Biol; 1996 Mar; 398():531-4. PubMed ID: 8906317
    [No Abstract] [Full Text] [Related]

  • 9. Benzoylalanine analogues as inhibitors of rat brain kynureninase and kynurenine 3-hydroxylase.
    Giordani A, Corti L, Cini M, Marconi M, Pillan A, Ferrario R, Schwarcz R, Guidetti P, Speciale C, Varasi M.
    Adv Exp Med Biol; 1996 Mar; 398():499-505. PubMed ID: 8906311
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Kynurenine 3-mono-oxygenase inhibitors attenuate post-ischemic neuronal death in organotypic hippocampal slice cultures.
    Carpenedo R, Meli E, Peruginelli F, Pellegrini-Giampietro DE, Moroni F.
    J Neurochem; 2002 Sep; 82(6):1465-71. PubMed ID: 12354294
    [Abstract] [Full Text] [Related]

  • 12. Regulation of quinolinic acid synthesis by mitochondria and o-methoxybenzoylalanine.
    Chiarugi A, Moroni F.
    Adv Exp Med Biol; 1999 Sep; 467():233-9. PubMed ID: 10721061
    [Abstract] [Full Text] [Related]

  • 13. Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis.
    Chiarugi A, Cozzi A, Ballerini C, Massacesi L, Moroni F.
    Neuroscience; 2001 Sep; 102(3):687-95. PubMed ID: 11226705
    [Abstract] [Full Text] [Related]

  • 14. The preferred route of kynurenine metabolism in the rat.
    Bender DA, McCreanor GM.
    Biochim Biophys Acta; 1982 Jul 16; 717(1):56-60. PubMed ID: 7104391
    [Abstract] [Full Text] [Related]

  • 15. 28833, a selective kynurenine 3-hydroxylase inhibitor. Effects on the kynurenine pathway metabolites in the gerbil.
    Cini M, Bormetti R, Marconi M, Molinari A, Veneroni O, Varasi M, Schwarcz R, Speciale C.
    Adv Exp Med Biol; 1996 Jul 16; 398():535-8. PubMed ID: 8906318
    [No Abstract] [Full Text] [Related]

  • 16. Metabolism of [5-3H]kynurenine in the rat brain in vivo: evidence for the existence of a functional kynurenine pathway.
    Guidetti P, Eastman CL, Schwarcz R.
    J Neurochem; 1995 Dec 16; 65(6):2621-32. PubMed ID: 7595559
    [Abstract] [Full Text] [Related]

  • 17. Quinolinic acid lesion of the nigrostriatal pathway: effect on turning behaviour and protection by elevation of endogenous kynurenic acid in Rattus norvegicus.
    Miranda AF, Sutton MA, Beninger RJ, Jhamandas K, Boegman RJ.
    Neurosci Lett; 1999 Mar 05; 262(2):81-4. PubMed ID: 10203236
    [Abstract] [Full Text] [Related]

  • 18. The kynurenine metabolic pathway in the eye: studies on 3-hydroxykynurenine, a putative cataractogenic compound.
    Chiarugi A, Rapizzi E, Moroni F, Moroni F.
    FEBS Lett; 1999 Jun 18; 453(1-2):197-200. PubMed ID: 10403402
    [Abstract] [Full Text] [Related]

  • 19. Perinatal kynurenine 3-hydroxylase inhibition in rodents: pathophysiological implications.
    Ceresoli-Borroni G, Guidetti P, Amori L, Pellicciari R, Schwarcz R.
    J Neurosci Res; 2007 Mar 18; 85(4):845-54. PubMed ID: 17279543
    [Abstract] [Full Text] [Related]

  • 20. Screening marine natural products for selective inhibitors of key kynurenine pathway enzymes.
    Feng Y, Bowden BF, Kapoor V.
    Redox Rep; 2000 Mar 18; 5(2-3):95-7. PubMed ID: 10939281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.